UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer

Gynecologic oncology, 2017-04, Vol.145 (1), p.27-31

2017

Volltextzugriff (PDF)

Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study

Journal of thrombosis and thrombolysis, 2017-02, Vol.43 (2), p.166-171

2017

Volltextzugriff (PDF)

Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy

Radiology, 2013-10, Vol.269 (1), p.149

2013

Volltextzugriff (PDF)

Rivaroxaban treatment of cancer‐associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience

Research and practice in thrombosis and haemostasis, 2019-07, Vol.3 (3), p.349-356

2019

Volltextzugriff (PDF)

Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia

Journal of clinical oncology, 2019-11, Vol.37 (31), p.2892-2898

2019

Volltextzugriff (PDF)

Prognostic Nomogram for Renal Insufficiency After Radical or Partial Nephrectomy

The Journal of urology, 2006-08, Vol.176 (2), p.472-476

2006

Volltextzugriff (PDF)

A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative

Gynecologic oncology, 2020-09, Vol.158 (3), p.608-613

2020

Volltextzugriff (PDF)

Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease

Gynecologic oncology, 2019-07, Vol.154 (1), p.72-76

2019

Volltextzugriff (PDF)

Prospective Study of the Correlation Between Postoperative Computed Tomography Scan and Primary Surgeon Assessment in Patients With Advanced Ovarian, Tubal, and Peritoneal Carcinoma Reported to Have Undergone Primary Surgical Cytoreduction to Residual Disease 1 cm or Less

Journal of clinical oncology, 2007-11, Vol.25 (31), p.4946-4951

2007

Volltextzugriff (PDF)

Is It Time to Centralize Ovarian Cancer Care in the United States?

Annals of surgical oncology, 2016-03, Vol.23 (3), p.989-993

2016

Volltextzugriff (PDF)

A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer

Gynecologic oncology, 2020-04, Vol.157 (1), p.214-221

2020

Volltextzugriff (PDF)

Limitations of CT During PET/CT

The Journal of nuclear medicine (1978), 2007-10, Vol.48 (10), p.1583-1591

2007

Volltextzugriff (PDF)

Is It Time to Centralize Ovarian Cancer Care in the United States?

Obstetrical & gynecological survey, 2016-02, Vol.71 (2), p.80-81

2016

Volltextzugriff (PDF)

Development and Baseline Characterization of a Thrombosis Risk Alert Tool: A Quality Assessment Project

Blood, 2020-11, Vol.136 (Supplement 1), p.18-19

2020

Volltextzugriff (PDF)

Follow-Up Study of the Correlation Between Postoperative Computed Tomographic Scan and Primary Surgeon Assessment in Patients With Advanced Ovarian, Tubal, or Peritoneal Carcinoma Reported to Have Undergone Primary Surgical Cytoreduction to Residual Disease of 1 cm or Smaller

International journal of gynecological cancer, 2010-04, Vol.20 (3), p.353-357-357

2010

Volltextzugriff (PDF)

Cancer-Associated Thrombosis: Anatomic Distribution of the Index Event Is Not a Reliable Predictor of Recurrence Risk

Blood, 2018-11, Vol.132 (Supplement 1), p.1252-1252

2018

Volltextzugriff (PDF)

Safe and Effective Use of Rivaroxaban for Treatment of Cancer Associated Venous Thromboembolic Disease

Blood, 2018-11, Vol.132 (Supplement 1), p.2536-2536

2018

Volltextzugriff (PDF)

Ovarian vein thrombosis after debulking surgery for ovarian cancer: epidemiology and clinical significance

American journal of obstetrics and gynecology, 2015-08, Vol.213 (2), p.208.e1-208.e4

2015

Volltextzugriff (PDF)

Prognostic nomogram for renal insufficiency after radical or partial nephrectomy. Commentary

The Journal of urology, 2006, Vol.176 (2), p.472-476

2006

Volltextzugriff (PDF)

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)

Gynecologic oncology, 2024-03, Vol.182, p.75-81

2024

Volltextzugriff (PDF)

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

Gynecologic oncology, 2023-02, Vol.169, p.64-69

2023

Volltextzugriff (PDF)

Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma

British journal of haematology, 2009-09, Vol.146 (6), p.652-655

2009

Volltextzugriff (PDF)

Time to Treatment Response in Patients with Follicular Lymphoma Treated with Bortezomib Is Longer Compared with Other Histologic Subtypes

Clinical cancer research, 2010-01, Vol.16 (2), p.719-726

2010

Volltextzugriff (PDF)

Implementation of evidence-based guidelines for thyroid nodule biopsy: a model for establishment of practice standards

American journal of roentgenology (1976), 2011-03, Vol.196 (3), p.655

2011

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer

Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study

Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy

Rivaroxaban treatment of cancer‐associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience

Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia

Prognostic Nomogram for Renal Insufficiency After Radical or Partial Nephrectomy

A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative

Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease

Prospective Study of the Correlation Between Postoperative Computed Tomography Scan and Primary Surgeon Assessment in Patients With Advanced Ovarian, Tubal, and Peritoneal Carcinoma Reported to Have Undergone Primary Surgical Cytoreduction to Residual Disease 1 cm or Less

Is It Time to Centralize Ovarian Cancer Care in the United States?

A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer

Limitations of CT During PET/CT

Is It Time to Centralize Ovarian Cancer Care in the United States?

Development and Baseline Characterization of a Thrombosis Risk Alert Tool: A Quality Assessment Project

Follow-Up Study of the Correlation Between Postoperative Computed Tomographic Scan and Primary Surgeon Assessment in Patients With Advanced Ovarian, Tubal, or Peritoneal Carcinoma Reported to Have Undergone Primary Surgical Cytoreduction to Residual Disease of 1 cm or Smaller

Cancer-Associated Thrombosis: Anatomic Distribution of the Index Event Is Not a Reliable Predictor of Recurrence Risk

Safe and Effective Use of Rivaroxaban for Treatment of Cancer Associated Venous Thromboembolic Disease

Ovarian vein thrombosis after debulking surgery for ovarian cancer: epidemiology and clinical significance

Prognostic nomogram for renal insufficiency after radical or partial nephrectomy. Commentary

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma

Time to Treatment Response in Patients with Follicular Lymphoma Treated with Bortezomib Is Longer Compared with Other Histologic Subtypes

Implementation of evidence-based guidelines for thyroid nodule biopsy: a model for establishment of practice standards

Suchergebnisse filtern